Neumora Therapeutics (NMRA) Earnings Date, Estimates & Call Transcripts $0.68 +0.03 (+4.12%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Neumora Therapeutics Earnings Summary Upcoming Earnings DateMay. 6EstimatedConsensus EPS (Mar. 6) -$0.46 Actual EPS (Mar. 6) -$0.37 Beat By $0.09 Neumora Therapeutics released Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.37, which topped the consensus estimate of -$0.46 by $0.09. With a trailing EPS of -$1.53, Neumora Therapeutics' earnings are expected to grow next year, from ($1.61) to ($1.54) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)NMRA Upcoming EarningsNeumora Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Monday, May 12, 2025 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Neumora Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neumora Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNMRA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads Neumora Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.46-$0.37-$0.42Q2 20252-$0.42-$0.39-$0.41Q3 20252-$0.42-$0.41-$0.42Q4 20252-$0.43-$0.43-$0.43FY 20258-$1.73-$1.60-$1.67Q1 20261-$0.44-$0.44-$0.44Q2 20261-$0.42-$0.42-$0.42Q3 20261-$0.43-$0.43-$0.43Q4 20261-$0.45-$0.45-$0.45FY 20264($1.74)($1.74)($1.74) Remove Ads Neumora Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------3/6/2025Q4 2024-$0.46-$0.37+$0.09-$0.37--11/12/2024Q3 2024-$0.39-$0.45 -$0.06-$0.45--8/6/2024Q2 2024-$0.37-$0.37--$0.37--5/7/2024Q1 2024-$0.34-$0.34--$0.34--3/7/2024Q4 2023-$0.76-$0.71+$0.05-$0.71--11/1/2023Q3 2023-$0.35-$1.14 -$0.79-$1.14-- Neumora Therapeutics Earnings - Frequently Asked Questions When is Neumora Therapeutics's earnings date? Neumora Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on NMRA's earnings history. Did Neumora Therapeutics beat their earnings estimates last quarter? In the previous quarter, Neumora Therapeutics (NASDAQ:NMRA) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.46) by $0.09. Learn more on analysts' earnings estimate vs. NMRA's actual earnings. How can I listen to Neumora Therapeutics's earnings conference call? The conference call for Neumora Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Neumora Therapeutics's conference call transcript? The conference call transcript for Neumora Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Neumora Therapeutics generate each year? Neumora Therapeutics (NASDAQ:NMRA) has a recorded net income of -$235.93 million. NMRA has generated -$1.53 earnings per share over the last four quarters. What is Neumora Therapeutics's EPS forecast for next year? Neumora Therapeutics's earnings are expected to grow from ($1.61) per share to ($1.54) per share in the next year. More Earnings Resources from MarketBeat Related Companies GH Research Earnings Alumis Earnings uniQure Earnings Bicycle Therapeutics Earnings Kura Oncology Earnings UroGen Pharma Earnings MeiraGTx Earnings Immatics Earnings Arvinas Earnings Sionna Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s Next Remove Ads This page (NASDAQ:NMRA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NMRA Stock Free NMRA Stock Alerts